MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

XOMA Corp Company Profile (NASDAQ:XOMA)

Consensus Ratings for XOMA Corp (NASDAQ:XOMA) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.08 (234.62% upside)

Analysts' Ratings History for XOMA Corp (NASDAQ:XOMA)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2016Piper JaffrayReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016RBC CapitalReiterated RatingSector Perform$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016WedbushReiterated RatingOutperform$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Jefferies GroupBoost Price TargetHold$1.00 -> $1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Deutsche BankReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2015Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015SusquehannaDowngradePositive -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Credit SuisseReiterated RatingNeutral$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/10/2014Roth CapitalInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for XOMA Corp (NASDAQ:XOMA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/4/2016($0.12)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.15)$0.21$4.01 million$48.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.16)($0.18)$3.55 million$2.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.18)($0.20)$4.38 million$2.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.16)($0.19)$4.31 million$2.65 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2015Q414($0.14)($0.12)$10.70 million$4.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.17)($0.17)$7.00 million$5.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.21)($0.17)$5.32 million$5.97 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.17)($0.23)$7.40 million$3.41 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014Q413($0.19)($0.55)$7.92 million$8.45 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.18)($0.21)$7.87 million$6.31 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.19)($0.21)$9.30 million$7.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.21)($0.39)$11.69 million$7.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for XOMA Corp (NASDAQ:XOMA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.10)($0.10)($0.10)
Q2 20162($0.15)($0.09)($0.12)
Q3 20162($0.15)($0.10)($0.13)
Q4 20162($0.15)($0.12)($0.14)
Q1 20171($0.14)($0.14)($0.14)
Q2 20171($0.15)($0.15)($0.15)
Q3 20171($0.15)($0.15)($0.15)
Q4 20171($0.14)($0.14)($0.14)
(Data provided by Zacks Investment Research)
Dividend History for XOMA Corp (NASDAQ:XOMA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for XOMA Corp (NASDAQ:XOMA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/22/2016John VarianCEOSell81,022$0.78$63,197.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Patrick J Md Phd ScannonVPSell14,785$0.78$11,532.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Paul D RubinCMOSell24,194$0.78$18,871.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Patrick J Md Phd ScannonVPSell8,000$1.01$8,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2015Patrick J Md Phd ScannonVPSell8,000$1.37$10,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2015Patrick J Md Phd ScannonVPSell8,000$1.35$10,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015Patrick J Md Phd ScannonVPSell8,000$1.04$8,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2015Bros. Advisors Lp BakerInsiderSell11,000,000$1.09$11,990,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015John VarianCEOSell10,000$4.49$44,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Paul D RubinCMOSell5,000$4.60$23,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Paul D RubinCMOSell33,400$4.55$151,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015John VarianCEOSell10,000$3.64$36,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015John VarianCEOSell10,000$3.86$38,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Paul D RubinCMOSell32,742$3.94$129,003.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015John VarianCEOSell10,000$3.72$37,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Patrick J Md Phd ScannonVPSell5,000$3.52$17,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2015John VarianCEOSell10,000$3.46$34,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2015Bros. Advisors Lp BakerDirectorSell2,215,400$3.81$8,440,674.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Patrick J Md Phd ScannonVPSell5,000$3.55$17,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2014Bros. Advisors Lp BakerDirectorSell744,000$3.67$2,730,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2014Bros. Advisors Lp BakerDirectorSell1,605,100$4.26$6,837,726.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Bros. Advisors Lp BakerDirectorSell1,033,800$4.46$4,610,748.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014John VarianCEOSell10,000$4.49$44,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Paul D RubinCMOSell1,600$4.63$7,408.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Bros. Advisors Lp BakerDirectorSell392,353$4.62$1,812,670.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Bros. Advisors Lp BakerDirectorSell2,372,206$4.79$11,362,866.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Patrick J Md Phd ScannonVPSell5,000$5.51$27,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014James R NealVPSell1,678$5.67$9,514.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014James R NealVPSell1,032$5.03$5,190.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014Paul D RubinCMOSell5,000$4.55$22,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Fred KurlandCFOSell8,773$3.89$34,126.97View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014James R NealVPSell4,387$3.89$17,065.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014John VarianCEOSell58,844$3.89$228,903.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Patrick J Md Phd ScannonVPSell5,000$4.33$21,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Paul D RubinCMOSell5,000$4.57$22,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2014John VarianCEOSell10,000$3.87$38,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Patrick J Md Phd ScannonVPSell5,000$4.09$20,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014John VarianCEOSell10,000$4.56$45,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Paul D RubinCMOSell5,000$4.59$22,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Paul D RubinCMOSell10,000$4.56$45,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Patrick J Md Phd ScannonVPSell5,000$4.31$21,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Paul D RubinCMOSell26,748$4.34$116,086.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Fred KurlandCFOSell10,401$4.31$44,828.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014John VarianCEOSell64,823$4.30$278,738.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Patrick J Md Phd ScannonVPSell5,871$4.31$25,304.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Patrick J Md Phd ScannonVPSell5,000$3.83$19,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014John VarianCEOSell10,000$4.03$40,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Patrick J Md Phd ScannonVPSell5,000$4.68$23,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014John VarianCEOSell10,000$4.54$45,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Paul D RubinCMOSell11,580$4.54$52,573.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2014Paul D RubinCMOSell1,785$4.22$7,532.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014John VarianCEOSell10,000$3.55$35,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2014John VarianCEOSell10,000$4.06$40,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Fred KurlandCFOSell5,915$6.32$37,382.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014John VarianCEOSell21,329$6.32$134,799.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Patrick Md Phd ScannonVPSell3,419$6.32$21,608.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Paul RubinCMOSell17,649$6.31$111,365.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Thomas KleinInsiderSell30,965$6.32$195,698.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014John VarianCEOSell10,000$6.03$60,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014John VarianCEOSell10,000$7.55$75,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Paul RubinCMOSell6,000$7.55$45,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2014Paul RubinCMOSell6,000$8.27$49,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014John VarianCEOSell10,000$8.28$82,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Patrick Md Phd ScannonVPSell20,000$8.00$160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2013Paul RubinCMOSell6,000$5.67$34,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2013John VarianCEOSell10,000$5.44$54,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013Patrick Md Phd ScannonVPSell20,000$6.00$120,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2013Paul RubinCMOSell4,696$4.54$21,319.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2013Paul RubinCMOSell1,304$4.08$5,320.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013John VarianCEOSell64,932$3.95$256,481.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013John VarianCEOSell10,000$4.60$46,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Paul RubinCMOSell6,000$4.53$27,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013John VarianCEOSell10,000$4.59$45,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Bros. Advisors Lp BakerDirectorBuy2,757,791$3.62$9,983,203.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Paul RubinCMOSell6,000$3.74$22,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013John VarianCEOSell61,647$3.87$238,573.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Fred KurlandCFOSell7,498$3.86$28,942.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Patrick Md Phd ScannonVPSell6,002$3.86$23,167.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Paul RubinCMOSell10,520$3.86$40,607.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2013Paul D RubinCMOSell6,000$4.71$28,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013John VarianCEOSell10,000$4.81$48,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2013Paul D RubinCMOSell1,797$4.16$7,475.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013Paul D RubinCMOSell6,000$0.54$3,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Fred KurlandCFOSell9,111$2.56$23,324.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012John VarianCEOSell40,587$2.56$103,902.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Patrick J Md Phd ScannonEVPSell8,773$2.56$22,458.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2012Julian BakerDirectorBuy4,722,666$3.00$14,167,998.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for XOMA Corp (NASDAQ:XOMA)
DateHeadline
06/29/16 10:02 AMAnalyst Rating Update on XOMA Corporation (XOMA) - Trade Calls
06/29/16 10:02 AMXOMA Corporation (XOMA) Hits New 52-week Low During June 27 Session - Equities.com
06/29/16 10:02 AMCompany Update (NASDAQ:XOMA): XOMA Corp Initiates Phase 2 Proof-of-Concept Study of XOMA 213 - Smarter Analyst
06/28/16 07:20 PMBRIEF-Xoma initiates Phase 2 proof-of-concept study of Xoma 213
06/28/16 07:20 PMXOMA Corporation (XOMA) Hits New 52-week Low During June 27 Session
06/28/16 08:11 AMXOMA Initiates Phase 2 Proof-of-Concept Study of XOMA 213 - [at noodls] - June 28, 2016 BERKELEY, Calif., June 28, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it has initiated its ...
06/28/16 08:05 AM9:05 am XOMA initiates its Phase 2 proof-of-concept study for XOMA 213 -
06/27/16 07:06 PMXOMA Corporation June 15th Short Interest Update - TheFounders Daily
06/27/16 07:06 PMAnalyst's Overview of Two Stocks: MannKind Corporation (NASDAQ:MNKD) , XOMA Corporation (NASDAQ:XOMA) - Street Updates
06/27/16 07:06 PMHC Stocks Overview: XOMA Corp (NASDAQ:XOMA), Biostar Pharmaceuticals Inc (NASDAQ:BSPM) - share market updates (press release)
06/26/16 04:34 AMXoma Corporation (NASDAQ:XOMA) Sellers Covered 4.34% of Their Shorts - Press Telegraph
06/24/16 07:21 PMPrice Target Update on XOMA Corporation (NASDAQ:XOMA) - Trade Calls
06/23/16 08:11 PMStrong Sell Calls Recommendations For XOMA Corporation (NASDAQ:XOMA) At 0 - Investor Newswire
06/23/16 09:53 AMXOMA Corporation (NASDAQ:XOMA) Analyst Rating Consensus - TheFounders Daily
06/20/16 02:29 PMETF’s with exposure to XOMA Corp. : June 20, 2016 -
06/20/16 08:42 AMEarnings Surprise in Focus: XOMA Corporation (NASDAQ:XOMA) - Investor Newswire
06/18/16 04:40 AMXOMA Corporation (XOMA) Hits New 52-week Low During June 16 Session - Equities.com
06/16/16 07:33 PMXOMA Corporation (XOMA) is Trading Lower on Unusual Volume for June 14 - Equities.com
06/16/16 07:33 PMXOMA Corporation (XOMA) Hits New 52-week Low During June 15 Session - Equities.com
06/16/16 07:34 AMXOMA Corporation (XOMA) Hits New 52-week Low During June 14 Session - Equities.com
06/15/16 04:27 AMAnalyst Price Target Update on XOMA Corporation (NASDAQ:XOMA) - TheFounders Daily
06/13/16 10:18 AMHC Stocks Newsbeat: Thermo Fisher Scientific Inc. (NYSE:TMO), XOMA Corp (NASDAQ:XOMA) - share market updates (press release)
06/03/16 10:30 AMHC Stocks Movements Activity: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), XOMA Corp (NASDAQ:XOMA) - share market updates (press release)
06/02/16 01:05 PMXOMA to Present at the Jefferies Global Healthcare Conference - [at noodls] - June 2, 2016 BERKELEY, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that John Varian, the ...
05/24/16 10:15 PMUveitis Treatment Market to expand at a CAGR of 7.3% , Globally from 2014 to 2020 - Request Brochure of this Report: http://www.persistencemarketresearch.com/samples/4430 pSivida Corp., XOMA Corporation, Alcon, Inc., Allergan, Inc., AbbVie Inc., Enzo Biochem Inc., OphthaliX Inc., Bausch & Lomb Incorporated, Regeneron Pharmaceuticals ...
05/24/16 08:42 AMHow Many XOMA Corp (NASDAQ:XOMA)'s Analysts Are Bullish? - Wall Street Hints and News - How Many XOMA Corp (NASDAQ:XOMA)'s Analysts Are Bullish?Wall Street Hints and NewsOut of 4 analysts covering Xoma Limited (NASDAQ:XOMA), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. Xoma Limited has been the topic of 8 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Below is a ...and more »
05/23/16 09:51 AMHot HC Stocks 2016: Mast Therapeutics Inc (NYSEMKT:MSTX), XOMA Corp (NASDAQ:XOMA) - share market updates (press release) - Hot HC Stocks 2016: Mast Therapeutics Inc (NYSEMKT:MSTX), XOMA Corp (NASDAQ:XOMA)share market updates (press release)Shares of Mast Therapeutics Inc (NYSEMKT:MSTX) closed at $0.300 with 1.84 million shares getting traded. Post opening the session at $0.29, the shares hit an intraday low of $0.29 and an intraday high of $0.31 and the price vacillated in this range ...
05/23/16 05:02 AMXOMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security -
05/20/16 10:08 PMUveitis Treatment Market to expand at a CAGR of 7.3%, Globally from 2014 to 2020 - Request Brochure of this Report: http://www.persistencemarketresearch.com/samples/4430 pSivida Corp., XOMA Corporation, Alcon, Inc., Allergan, Inc., AbbVie Inc., Enzo Biochem Inc., OphthaliX Inc., Bausch & Lomb Incorporated, Regeneron Pharmaceuticals ...
05/20/16 05:00 PMXOMA Corp (XOMA) Performance Overview - News Oracle - News OracleXOMA Corp (XOMA) Performance OverviewNews OracleBy looking at XOMA Corp (NASDAQ:XOMA) YTD (year to date) performance, the stock shows Negative value of -48.43%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock is appreciating.Trading Overview of Two Stocks: Array BioPharma Inc. (NASDAQ:ARRY) , XOMA Corporation (NASDAQ:XOMA)Street UpdatesShare Recap and Earnings Focus on XOMA Corporation (NASDAQ:XOMA)Wall Street Hints and Newsall 28 news articles »
05/20/16 05:00 PMTrending Healthcare Stock in Focus: XOMA Corp (NASDAQ:XOMA) - News Oracle - News OracleTrending Healthcare Stock in Focus: XOMA Corp (NASDAQ:XOMA)News OracleBy looking at XOMA Corp (NASDAQ:XOMA) YTD (year to date) performance, the stock shows Negative value of -50.38%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock is appreciating.and more »
05/19/16 07:09 PMETF’s with exposure to XOMA Corp. : May 20, 2016 -
05/18/16 05:01 PMHC Stocks in Top Row: XOMA Corp (NASDAQ:XOMA), AbbVie Inc (NYSE:ABBV), Opko Health Inc. (NYSE:OPK) - share market updates (press release) - HC Stocks in Top Row: XOMA Corp (NASDAQ:XOMA), AbbVie Inc (NYSE:ABBV), Opko Health Inc. (NYSE:OPK)share market updates (press release)Shares of XOMA Corp (NASDAQ:XOMA) ended Tuesday session in green amid volatile trading. The shares closed up +0.004 points or 0.57% at $0.686 with 1.10 million shares getting traded. Post opening the session at $0.69, the shares hit an intraday low ...and more »
05/18/16 05:01 PMRevenue Update on XOMA Corp(NASDAQ:XOMA) - Trade Calls - News OracleRevenue Update on XOMA Corp(NASDAQ:XOMA)Trade CallsXOMA Corp(NASDAQ:XOMA) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 4, 2016. Company reported revenue of $3.96M. Analysts estimated a revenue of $870.00K. Earnings per share were ...XOMA Corp (XOMA) Performance OverviewNews OracleXoma Corporation (NASDAQ:XOMA) Shorted Shares Increased 0.65% After Market SellingWall Street Hints and NewsTrading Overview of Two Stocks: Array BioPharma Inc. (NASDAQ:ARRY) , XOMA Corporation (NASDAQ:XOMA)Street Updatesall 6 news articles »
05/18/16 01:01 PMXOMA Corp. :XOMA-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 09:59 PMXoma Corporation (NASDAQ:XOMA) Shorted Shares Increased 0.65% After Market Selling - Wall Street Hints and News - Xoma Corporation (NASDAQ:XOMA) Shorted Shares Increased 0.65% After Market SellingWall Street Hints and NewsThe stock of Xoma Corporation (NASDAQ:XOMA) registered an increase of 0.65% in short interest. XOMA's total short interest was 13.49M shares in May as published by FINRA. Its up 0.65% from 13.40M shares, reported previously. With 933,600 shares ...and more »
05/16/16 09:56 AMHC Stocks Growth: United Therapeutics Corporation (UTHR), XOMA Corp (XOMA), Pfizer Inc. (PFE) - share market updates (press release) - share market updates (press release)HC Stocks Growth: United Therapeutics Corporation (UTHR), XOMA Corp (XOMA), Pfizer Inc. (PFE)share market updates (press release)Shares of United Therapeutics Corporation (NASDAQ:UTHR) ended Friday session in green amid volatile trading. The shares closed up +2.25 points or 2.06% at $111.48 with 600,172.00 shares getting traded. Post opening the session at $109.47, the shares ...
05/15/16 03:06 AMXOMA Corporation (XOMA) Hits New 52-week Low During May 12 Session - XOMA Corporation (XOMA) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $0.70, XOMA Corporation dropped to $0.65 for a new 52-week low. By the closing bell, the company's stock was at $0.66 a share for ...
05/13/16 10:27 PMXOMA Corporation (XOMA) Hits New 52-week Low During May 12 Session - Equities.com - XOMA Corporation (XOMA) Hits New 52-week Low During May 12 SessionEquities.comXOMA Corporation (XOMA) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $0.70, XOMA Corporation dropped to $0.65 for a new 52-week low. By the closing bell, the company's stock was at $0.66 a ...
05/11/16 05:28 PMHC Stocks Alarms: Biocept (BIOC), Celgene (CELG), XOMA Corp (XOMA) - share market updates (press release) - share market updates (press release)HC Stocks Alarms: Biocept (BIOC), Celgene (CELG), XOMA Corp (XOMA)share market updates (press release)Shares of Biocept Inc (NASDAQ:BIOC) ended Tuesday session in red amid volatile trading. The shares closed down -0.016 points or -1.90% at $0.830 with 248,236.00 shares getting traded. Post opening the session at $0.88, the shares hit an intraday low of ...and more »
05/11/16 12:04 PMXOMA CORP Financials -
05/10/16 05:22 PMHC Stocks Highlights: CytRx Corporation (CYTR), Depomed Inc (DEPO), XOMA Corp (XOMA) - share market updates (press release) - HC Stocks Highlights: CytRx Corporation (CYTR), Depomed Inc (DEPO), XOMA Corp (XOMA)share market updates (press release)Shares of CytRx Corporation (NASDAQ:CYTR) ended Monday session in red amid volatile trading. The shares closed down -0.02 points or -0.65% at $3.07 with 830,335.00 shares getting traded. Post opening the session at $3.10, the shares hit an intraday ...and more »
05/07/16 04:45 PMQ1 Results: XOMA Corp (NASDAQ:XOMA) - share market updates (press release) - share market updates (press release)Q1 Results: XOMA Corp (NASDAQ:XOMA)share market updates (press release)Shares of XOMA Corp (NASDAQ:XOMA) ended Friday session in red amid volatile trading. The shares closed down -0.017 points or -2.34% at $0.723 with 922,104 shares getting traded. Post opening the session at $0.77, the shares hit an intraday low of ...Analyst Rating Fluctuations to Observe: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) , XOMA Corporation ...Street Updatesall 2 news articles »
05/06/16 05:17 PMEarnings Expectations of the Stock: XOMA Corp (NASDAQ:XOMA) - News Oracle - Web Breaking NewsEarnings Expectations of the Stock: XOMA Corp (NASDAQ:XOMA)News OracleLast Trade: The Company fell -1.62% and finished at $0.770. The daily volume was measured at 1.98 million shares. The 52-week high of the share price is $4.93 and the 52-week low is $0.69. The company has a market cap of $94.22 million. Its latest ...XOMA Corp (XOMA) Rating Reiterated by Cowen and CompanyWeb Breaking NewsXOMA Corporation (XOMA) - Broker UpdateRisers & FallersBiotech Stocks To Put On Your Watch List: XOMA Corporation (NASDAQ:XOMA), Opko Health, Inc. (NYSE:OPK)Street RegisterNews Tribuneall 11 news articles »
05/06/16 03:54 AMXOMA Corporation (NASDAQ:XOMA) Upcoming Earnings: What matter for investors? - XOMA Corporation (XOMA) retreated -1.27% to reach at the floor price of $0.77 as the company is set to share its latest quarterly earnings after to closing bell on May 05, 2016. XOMA stock trades between $0.74 and $0.8 before the earnings release.
05/05/16 10:47 PMCowen & Co. Reiterates a Hold Rating on Xoma Corp - Analyst Ratings - Cowen & Co. Reiterates a Hold Rating on Xoma CorpAnalyst RatingsAccording to The Fly, in a report released yesterday, Phil Nadeau from Cowen & Co. reiterated a Hold rating on Xoma Corp (NASDAQ: XOMA). The company's shares opened today at $0.79, close to its 52-week low of $0.69. Nadeau observed, “XOMA ended ...and more »
05/04/16 10:26 PMBRIEF-Xoma Corp Q1 loss per share $0.07 - Reuters - BRIEF-Xoma Corp Q1 loss per share $0.07ReutersMay 4 Xoma Corp : * Xoma reports first quarter 2016 operational achievements and financial results. * Qtrly total revenues $4 million versus $2.7 million; qtrly loss per share $0.07 Source text for Eikon: Further company coverage: (Bengaluru Newsroom).
05/04/16 10:26 PMStock Update (NASDAQ:XOMA): XOMA Corp Reports First Quarter 2016 Operational Achievements and Financial ... - Smarter Analyst - Stock Update (NASDAQ:XOMA): XOMA Corp Reports First Quarter 2016 Operational Achievements and Financial ...Smarter AnalystXOMA Corp (NASDAQ:XOMA), a leader in the discovery and development of therapeutic antibodies, announced recent operational achievements and financial results for the first quarter ended March 31, 2016. “Our efforts are squarely focused on generating ...XOMA Reports First Quarter 2016 Operational Achievements and Financial ResultsNasdaqall 1 news articles »
04/04/16 08:17 AMXOMA Presented First Data from Novel Antibody Fragment to Address Severe Acute Hypoglycemia at the ENDO Meeting - [at noodls] - April 4, 2016 BERKELEY, Calif., April 04, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced the presentation of data ...
03/29/16 10:06 AMETF’s with exposure to XOMA Corp. : March 29, 2016 -
About XOMA Corp

XOMA Corp logoXOMA Corporation is engaged in the discovery and development of antibody-based therapeutics. The Company's lead product candidate, gevokizumab, is a potent, humanized allosteric-modulating monoclonal antibody that binds to the inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company has initiated three pivotal clinical trials evaluating gevokizumab for the treatment of non-infectious intermediate, posterior or pan-uveitis (NIU) and Behcet's disease uveitis. The Company also has a gevokizumab Proof-of-Concept (POC) development program to identify other illness for late-stage development. These studies are known as the EYEGUARD program, which includes EYEGUARD-A (patients with active NIU), EYEGUARD-B (patients with Behcet's disease uveitis outside of the United States), and EYEGUARD-C (patients with a history of NIU controlled with systemic treatment).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: XOMA
  • CUSIP: 98419J10
Key Metrics:
  • Previous Close: $0.45
  • 50 Day Moving Average: $0.6406
  • 200 Day Moving Average: $0.8618
  • P/E Ratio: N/A
  • P/E Growth: -0.0500
  • Market Cap: $58.49M
  • Current Quarter EPS Consensus Estimate: $-0.4500 EPS
Additional Links:
XOMA Corp (NASDAQ:XOMA) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha